You just read:

Regeneron and Alnylam Announce Broad Collaboration to Discover, Develop and Commercialize RNAi Therapeutics Focused on Ocular and Central Nervous System (CNS) Diseases

News provided by

Regeneron Pharmaceuticals, Inc.

Apr 08, 2019, 07:00 ET